SurfWax News Index  |  Track News  |  Save/Exchange Information |  About Us

    News and Articles on PNL Nephrolithotripsy

    Archives: PNL Nephrolithotripsy

    Angioplasty Scoring System Predicts Risk of Death  Aug 29, 2008
    The Mayo Clinic Risk Score (MCRS) uses seven simple clinical and non-invasive variables to predict in-hospital death for percutaneous coronary intervention (PCI), the most widely performed heart revascularization process in the United States. In 2005, doctors in the United States did more than 1. (MEDLINEplus)

    Comedian Dana Carvey To Be A Special Guest At "Controversies And Advances" Symposium For Heart Specialists  Aug 27, 2008
    Topic: "A Tribute to Andreas Gruentzig: A 30-year Odyssey and His Legacy of Percutaneous Coronary Intervention.". Eduardo Marb;n, M.D., Ph. (Yahoo News -- Press Releases)

    Angioplasty No Better Than Drug Treatment in Long Run  Aug 15, 2008
    Earlier analysis found improved quality of life for those having the artery-opening procedure that is formally called percutaneous coronary intervention (PCI). The latest report, in the Aug. 14 issue of the New England Journal of Medicine, found that by 36 months, there was no significant difference in health status between the two treatment groups. (MEDLINEplus)

    Drugs, angioplasty give similar life quality: study  Aug 14, 2008
    The surgery, known as PCI for percutaneous coronary intervention, may provide more short-term relief for some patients with severe or more frequent chest but the benefits tend to fade over the years, the international team of researchers reported in the New England Journal of Medicine. They assessed 2,287 volunteers in 50 U.S. and Canadian medical centers as part of a study called COURAGE, for Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation. (Scientific American)

    Bivalirudin vs. Unfractionated Heparin during PCI  Aug 14, 2008
    NEJM -- Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention ... Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention ... Background Whether bivalirudin is superior to unfractionated heparin in patients with stable or unstable angina who undergo percutaneous coronary intervention (PCI) after pretreatment with clopidogrel is unknown. (New England Journal of Medicine)

    Effect of PCI on Quality of Life in Patients with Stable Coronary Disease  Aug 14, 2008
    Background It has not been clearly established whether percutaneous coronary intervention (PCI) can provide an incremental benefit in quality of life over that provided by optimal medical therapy among patients with chronic coronary artery disease. Methods We randomly assigned 2287 patients with stable coronary disease to PCI plus optimal medical therapy or to optimal medical therapy alone. (New England Journal of Medicine)

    Finding the Courage to Reconsider Medical Therapy for Stable Angina  Aug 14, 2008
    Percutaneous coronary intervention (PCI), which was limited at that time to balloon angioplasty, was an alternative. However, the risks associated with the procedure and the rate of restenosis largely relegated it to second-line therapy for patients who did not have a response to best medical therapy. (New England Journal of Medicine)

    Ospedale Niguarda Ca' Granda-Milano Adopts Latest Technology to Treat Patients with Heart Failure  Aug 6, 2008
    The catheter-based, percutaneous device addresses patients suffering from acute decompensated heart failure by moving blood from an iliac artery to the descending aorta through the use of an extracorporeal circulatory support ... The percutaneous Cancion System bears the CE mark of conformity, and the implantable Exeleras(R) System is in development. (PR Newswire)

    Endoscopic Circumferential Ablation Promising For Barrett's Esophagus With High-grade Dysplasia  Aug 5, 2008
    9, 2006) Percutaneous radiofrequency ablation, a procedure that uses a high frequency electric current to kill tumor cells, is effective in achieving local control in selected patients with metastasis from. . (Science Daily)

    Time to Take Myocardial Reperfusion Injury Seriously  Jul 31, 2008
    1 Timely and effective reperfusion with the use of either primary percutaneous coronary intervention (PCI) or thrombolytic therapy remains the most effective treatment strategy for limiting the size of the myocardial infarct, preserving left ventricular ejection fraction, and improving the clinical outcomes in such patients. However, despite optimal reperfusion therapy, morbidity and mortality remain substantial, with about 5 to 6% of patients having a subsequent cardiovascular event by 30 days. (New England Journal of Medicine)

    Stents versus Bypass Grafting for Left Main Coronary Artery Disease  Jul 24, 2008
    To the Editor: Seung et al. (April 24 issue)1 report that there was no significant difference in rates of death and major cardiovascular events between matched cohorts of patients undergoing coronary-artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) for left main coronary artery disease a finding that contrasts with recently published data. 2 The authors, however, did not consider variables that are significantly and independently associated with in-hospital or 30-day... (New England Journal of Medicine)

    Heart Attack Not A Death Sentence  Jul 22, 2008
    (May 10, 2007) When compared with intensive drug therapy, percutaneous coronary intervention (PCI, angioplasty) was more beneficial in reducing the long-term risk of major cardiac events among heart attack. (Feb. (Science Daily)

    PCI preference -- will that be an arm or a leg?  Jul 19, 2008
    Researchers reviewed data from 593,094 cases of percutaneous coronary intervention (PCI) in 606 hospitals across the U.S. included in the National Cardiovascular Data Registry from 2004 to 2007. They tracked the incidence of radial PCI (r-PCI) versus leg or femoral PCI (f-PCI) during that period and calculated which patients were more likely to get which option. (EurekAlert!)

    Blood Vessel Inhibitor Shows Promise Against Metastatic Thyroid Cancer  Jul 7, 2008
    (June 5, 2007) Percutaneous ethanol injection -- an injection of ethanol through the skin directly into a bone tumor to kill cancer cells -- may be a valuable ancillary treatment for thyroid cancer patients whose. (Oct. (Science Daily)

    First Pharmaceutical Drug To Improve Survival Amongst Patients With Advanced Hepatocarcinoma  Jun 30, 2008
    In more than half the cases local curative treatment such as surgery, transplant or percutaneous ablation; or palliative ones, such as arterial embolisation or radioembolisation with radioactive spheres, can be applied. In the rest of the cases, the prognosis is not good but, in the last five years, there have appeared more than ten pharmaceutical medicines known as biological agents or directed pharmaceutical drugs, the use of which in this tumour is currently being actively investigated,... (Science Daily)

    Wellstar Kennestone meets top benchmark for treating heart attacks  Jun 28, 2008
    By The Atlanta Journal-Constitution Published on: 06/27/08. New data has revealed that 100 percent of WellStar Kennestone Hospital of Marietta's eligible heart attack patients in the first quarter of this year were treated in 90 minutes or less, with a median time of 58 minutes, Wellstar said Friday. (Atlanta Journal-Constitution -- Business)

    Acute Calculous Cholecystitis  Jun 26, 2008
    Percutaneous Cholecystostomy. Guidelines. (New England Journal of Medicine)

    Drug-Releasing Stents Decrease Repeat Cardiac Procedures  Jun 25, 2008
    0 percent, percutaneous coronary intervention [PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries]; 4. 2 percent, coronary artery bypass graft [CABG]). (Newsmax)

    FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel  Jun 24, 2008
    The proposed indication for prasugrel is for the treatment of patients with acute coronary syndromes (ACS) being managed with an artery- opening procedure known as percutaneous coronary intervention (PCI). Daiichi Sankyo and Lilly also confirm the start this month, as planned, of the TRILOGY ACS trial, a large Phase III clinical trial to compare the effects of prasugrel against clopidogrel (Plavix(R)/Iscover(R)) in medically managed ACS patients. (PR Newswire)

    First gene therapy for heart failure offered at NewYork-Presbyterian/Columbia  Jun 19, 2008
    Patients enrolled in the multicenter CUPID trial (Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease) will undergo a minimally invasive cardiac catheterization procedure that will introduce a specially engineered gene that stimulates production of an enzyme necessary for the heart to pump more efficiently. "This new therapy seeks to replenish the levels of this enzyme by introducing the gene for SERCA2a, which is depressed in these patients. If proven... (EurekAlert!)

    Non-Surgical Approach Can Treat Lung Cancers  Jun 18, 2008
    In the study, expected to be published in the July edition of The Lancet Oncology, 88 percent of lung cancer patients responded well to treatment with percutaneous image-guided radiofrequency ablation (RFA). RFA is performed in less than an hour and is a non-surgical procedure that targets large tumors with no harm to surrounding healthy tissue. (Health-Finder)

    Artery-Opening Method Works Well in Women  Jun 11, 2008
    The study in the June 17 issue of the Journal of the American College of Cardiology is a marker in a fading debate about the value for women of what cardiologists call percutaneous coronary intervention (PCI), in which a balloon-tipped catheter is inserted to open a blocked blood vessel. Older studies have reported a lower use of PCI for women and a higher death rate for those getting the intervention. (MEDLINEplus)

    Screening for Down Syndrome  Jun 8, 2008
    If the risk is high, the physician may recommend diagnostic testing such as chorionic villus sampling (CVS), amniocentesis or percutaneous umbilical blood sampling (PUBS). The copyright of the article Screening for Down Syndrome in General Medicine is owned by. (Suite101.com)

    New technique for heart attacks  Jun 8, 2008
    7 per cent who received the usual treatment percutaneous coronary intervention (PCI) ... The article reported on the one-year follow-up from a called the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS) ... Percutaneous coronary intervention (PCI) is suitable for some patients with heart attacks: those that have a catheter (tube) inserted in the groin and fed into the coronary artery where a balloon is inflated to re-open the artery. (NHS Choices)

    Sucking out Clot Debris Helps Heart Attack Patients  Jun 7, 2008
    All 1,071 people in the trial were given emergency treatment called percutaneous coronary intervention (PCI) for the kind of heart attack formally called ST-elevation myocardial infarction, a term that refers to the pattern traced out by an electrocardiogram. The usual treatment is insertion of a balloon-tipped catheter to reopen the blocked coronary artery. (MEDLINEplus)

    Medical Center Hospital receives Chest Pain Center accreditation  May 29, 2008
    "The Chest Pain Center Accreditation was a project that they themselves pursued and achieved. The CPC Accreditation speaks to the professionalism and dedication of the staff in the CPC, as well as the collegiality of the staff in The Center for Heart Disease. (Chest Pain Center, ED, ED physicians, Cardiology and the Cath Lab)." Neckels continued "It is the coordination of these departments and the relationships between these departments that allowed us to be successful not just in getting... (Odessa American, TX)

    Portsmouth Regional Hospital gets low marks  May 27, 2008
    Portsmouth gave PCI (Percutaneous coronary intervention, which is often the first treatment of choice for a type of heart attack that occurs when one of the coronary arteries is completely blocked, according the American Heart Association) in only 47 percent of the cases, while Exeter gave PCI to 93 percent of those with this type of heart attack and Wentworth-Douglass gave it in 67 percent of these cases. The goal of PCI is to prevent the death of heart muscle cells by restoring coronary blood... (Seacoast New Hampshire)

    Cardiac Rehab Referrals Up, But Not Enrollment  May 24, 2008
    Among the factors associated with higher referral rates were inpatient physical therapy consultation and percutaneous coronary intervention, also referred to as angioplasty, which involves insertion of a catheter into the coronary artery to remove the blockage that caused the heart attack. The researchers point out that referral rates were higher than the 10 to 15 percent reported in other studies. (MEDLINEplus)

    Findings released from 1 of the largest percutaneous coronary intervention trials ever  May 24, 2008
    HORIZONS-AMI is the largest study ever to focus on the appropriate use of anticoagulant medications in patients experiencing STEMI and undergoing primary percutaneous coronary intervention (PCI). Only 7. (EurekAlert!)

    Mixed Results for Anti-Clotting Drugs in Heart Attacks  May 23, 2008
    They are supposed to get what used to be called angioplasty and now goes by the formal medical name of percutaneous coronary intervention (PCI), in which a balloon-tipped catheter is threaded into a blocked artery, preferably within three hours of the attack. That goal is hard to achieve in many cases, often because a hospital equipped for PCI isn't close enough. (MEDLINEplus)

    Biopure Announces 2008 Second Quarter Financial Results  May 22, 2008
    The paper is entitled "Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularization. Rationale, protocol design, and haemodynamic results." The manuscript was authored by principal investigator Patrick W. Serruys, MD, PhD and colleagues of the Department of Interventional Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands. The paper concluded that this trial represents an important next step in the clinical development... (PR Newswire)

    Antithrombotic Therapy to Support Primary PCI  May 22, 2008
    1,2 The selection of the reperfusion strategy, either the preferred percutaneous coronary intervention (PCI) or fibrinolysis, is usually driven by institutional access to primary PCI. Thus, the decision that clinicians most commonly grapple with at the time of the patient's presentation is the selection of adjunctive anticoagulant and antiplatelet therapy ... Bivalirudin Alone During Primary Percutaneous Coronary Intervention. (New England Journal of Medicine)

    Bivalirudin during PCI for Acute Myocardial Infarction  May 22, 2008
    Background Treatment with the direct thrombin inhibitor bivalirudin, as compared with heparin plus glycoprotein IIb/IIIa inhibitors, results in similar suppression of ischemia while reducing hemorrhagic complications in patients with stable angina and non ST-segment elevation acute coronary syndromes who are undergoing percutaneous coronary intervention (PCI). The safety and efficacy of bivalirudin in high-risk patients are unknown. (New England Journal of Medicine)

    Thrombolytic Therapy and Primary PCI  May 22, 2008
    Sir Winston Churchill once said, "It's not enough that we do our best; sometimes we have to do what is required." Such a sentiment underlies the premise of facilitated percutaneous coronary intervention (PCI), a therapeutic strategy of pharmacologic thrombolysis before mechanical intervention for the treatment of ST-segment elevation myocardial infarction ... Facilitated Percutaneous Coronary Intervention for ST-Segment-Elevation MI: Achieving Closure. (New England Journal of Medicine)

    Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents  May 21, 2008
    Ltd. (SMT), Surat, India, leading developer and manufacturer of drug-eluting stents, welcomed the positive results of the prospective, randomized nine months results of PAINT trial (PercutAneous INTervention with biodegradable- polymer based paclitaxel-eluting, sirolimus-eluting, or bare stents for the treatment of de novo coronary lesions). The PAINT study was designed with a unique 3-arm format that allows the evaluation of three stents that only differ on the presence and/or type of drug (all... (PR Newswire)

    First Veterinary Corneal Implant Procedure In U.S. Performed On Dog  May 14, 2008
    29, 2007) The veterinary hospital at Oklahoma State University's Center for Veterinary Health Sciences offers percutaneous laser disc ablation surgery for canines and is the sole provider worldwide of the. (Feb. (Science Daily)

    ASGE issues updated guidelines on antibiotic prophylaxis for gastrointestinal endoscopy  May 14, 2008
    Examples of these special situations are prevention of cholangitis after ERCP with incomplete drainage of bile duct obstruction, prevention of pancreatic cyst infection after fine needle aspirate at endoscopic ultrasound or after injection of contrast at ERCP, and prior to placement of a percutaneous feeding tube placement. ASGE Guidelines. (EurekAlert!)

    Mitral Valve Leak Repaired Through Tiny Puncture Hole Using Live 3D Images  May 13, 2008
    The minimally invasive technique is called a percutaneous paravalvular leak repair, and it is performed in a catheterization lab rather than in an operating room. The duct occluder is made of a metal mesh that holds its place once deployed in the leak. (Science Daily)

    Patients Arriving At Hospitals In Off Hours Get Slower, Less Care  Apr 23, 2008
    After adjusting for baseline characteristics, patients arriving during off hours were 7 percent less likely to undergo primary percutaneous coronary intervention (PCI) and 6 percent less likely to undergo PCI or another type of revascularization called coronary artery bypass graft (CABG) compared with patients arriving during regular hours. "Emergency angioplasty, or PCI, is the preferred procedure after an ST-segment elevation myocardial infarction, which is a heart attack caused by a... (Science Daily)

    Patients Receive Heart Valve Replacements Without Surgery Using High-tech Device  Apr 21, 2008
    We were able to successfully implant the Edwards SAPIEN transcatheter heart valve percutaneously in the first three patients treated in this trial ... 23, 2007) Three new studies evaluate a rapidly advancing field within interventional cardiology: percutaneous procedures to repair and replace defective heart valves ... Percutaneous valve procedures, which are. (Science Daily)

    Primary PCI in ST-Segment Elevation MI  Apr 17, 2008
    7% of patients with ST-segment elevation myocardial infarction when paramedics interpreted the electrocardiograms (ECGs) and directly referred the patients to a percutaneous coronary intervention (PCI) center, as compared with 11. 9% of patients referred from emergency departments of the area's hospitals (including the PCI center). (New England Journal of Medicine)

    New Technique In Treating Patients With Liver Cancer Proves Effective, Study Suggests  Apr 15, 2008
    9, 2006) Percutaneous radiofrequency ablation, a procedure that uses a high frequency electric current to kill tumor cells, is effective in achieving local control in selected patients with metastasis from. (Mar. (Science Daily)

    New equipment approved for heart attack victims  Apr 11, 2008
    The comprehensive cardiac care system would designate the hospitals as ST-Segment Elevation Myocardial Infarction, or STEMI, receiving centers capable of performing an emergency cardiac catheterization method known as percutaneous coronary intervention, a procedure used to reopen clogged arteries. Receiving this procedure, which uses a catheter threaded into the coronary artery to open the blockage, within 90 minutes of arrival at a hospital is believed to result in a 38 percent reduction in the... (Palo Alto Online, CA)

    SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery  Apr 11, 2008
    Carotid artery stenting is a non-surgical, percutaneous procedure in which a small plastic tube called a catheter is inserted through an artery in the leg and threaded to the blockage in the neck. A thin wire (guidewire), which has a collapsible umbrella-like filter device attached to its end, is advanced passed the blockage. (EurekAlert!)

    Platelet Activation and Atherothrombosis  Apr 10, 2008
    In one study, after percutaneous coronary intervention, combination therapy for 1 year was associated with a 26. 9% relative reduction in the combined risk of death, myocardial infarction, or stroke. (New England Journal of Medicine)

    New data on 3M's Tegaderm CHG  Apr 8, 2008
    3M Tegaderm CHG has not been studied in a randomized clinical study as to its effectiveness in preventing CR-BSIs or other percutaneous device-related infections. Tegaderm CHG IV Securement Dressing combines the powerful antimicrobial protection of CHG with the simplicity of Tegaderm film dressings, making it easy to use. (EurekAlert! -- Business News)

    Vascular Solutions Wins $4.5 Million Jury Verdict in Litigation With Marine Polymer Technologies  Apr 8, 2008
    New products introduced since the second half of 2003 include the D-Stat Dry hemostatic bandage used for the rapid control of topical bleeding, the Pronto extraction catheter for the aspiration of soft thrombus, the Vari-Lase endovenous laser product line for the treatment of varicose veins, the Langston dual lumen specialty catheter for the measurement of aortic stenosis and the Twin-Pass dual access specialty catheter for dual wire access in percutaneous procedures. The information in this... (Primezone Releases)

    Momenta Pharmaceuticals Announces Presentation of M118 Phase 1 Results At the American Society for Clinical Pharmacology and Therapeutics Annual Meeting  Apr 4, 2008
    One of the key findings from the study was that an Activated Clotting Time (ACT) reading of greater than 200 seconds was achieved in the higher dose cohorts, suggesting that an intravenous bolus administration of M118 can produce ACT levels comparable to levels expected with standard heparin doses used in conjunction with Percutaneous Coronary Intervention (PCI) procedures ... The multi-center Phase 2a trial, or EMINENCE (Evaluation on M118 IN pErcutaNeous Coronary IntErvention), is expected to... (Primezone Releases)

    Heart Bypass Surgery Doesn't Cause Mental Decline  Apr 4, 2008
    com - Heart Bypass Surgery Doesnause Mental Decline. On a Handheld Device. (Newsmax)

    Angioplasty Proves Reasonable Alternative to Bypass Surgery  Apr 2, 2008
    MONDAY, March 31 (HealthDay News) -- For patients with blockages in the left main coronary artery, percutaneous coronary intervention -- PCI, often referred to as angioplasty -- may be a viable alternative to bypass surgery ... Current guidelines recommend coronary artery bypass grafting (CABG) over percutaneous coronary intervention unless a previous graft has been performed ... Percutaneous coronary intervention, which refers to a number of procedures used to treat arteries, is usually... (MEDLINEplus)

    Is PCI Safe, Effective After Clot-Busters for Heart Attack?  Mar 31, 2008
    Largest-ever study re-evaluates this important question with today's technology CHICAGO, March 30 /PRNewswire/ -- Percutaneous coronary intervention (PCI) -- which uses a combination of catheter-mounted balloons and stents to open a completely blocked coronary artery and restore blood flow to the heart -- is the best treatment for heart attack when performed rapidly. However, few hospitals can meet the 90-minute treatment goal unless they have a cardiac catheterization laboratory on site. (PR Newswire)

    Device That Clears Debris From Artery Aids Blood Flow in PCI  Mar 31, 2008
    Better clinical results with Export Aspiration Catheter hold up at one year CHICAGO, March 30 /PRNewswire/ -- Use of a special catheter that sucks out, or aspirates, bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) significantly enhances blood flow deep in the heart muscle in patients who are experiencing a heart attack, according to a recently published study. Now, a new analysis of the Thrombus Aspiration during Percutaneous Coronary Intervention... (PR Newswire)

    Filter Fails to Improve PCI Outcomes in Acute Coronary Syndromes  Mar 31, 2008
    Windsock-like device catches debris but doesn't avoid damage to heart muscle CHICAGO, March 30 /PRNewswire/ -- A device that catches bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) has failed to show that it can reduce rates of major cardiovascular complications in patients with acute coronary syndromes, a condition that encompasses unstable angina and a type of heart attack known as non-ST-elevation myocardial infarction (NSTEMI). Although the EZ... (PR Newswire)

    BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack  Mar 31, 2008
    With high-dose clopidogrel, the intravenous anti-platelet drug appears unnecessary CHICAGO, March 30 /PRNewswire/ -- Over the years, interventional cardiologists have made many improvements in percutaneous coronary intervention (PCI) for patients with heart attack, among the most important, refinements in the selection and administration of drugs that prevent unwanted blood clotting. Now a new study has found that high loading doses of clopidogrel, an oral medication that inhibits blood clots by... (PR Newswire)

    Drug-Eluting Stents Outperform Bare Stents in Heart Attack  Mar 31, 2008
    Anti-clotting drug tirofiban also edges abciximab CHICAGO, March 30 /PRNewswire/ -- New evidence from a large randomized study is answering important questions about the best approach to percutaneous coronary intervention (PCI) in patients with a type of heart attack known as ST-segment-elevation myocardial infarction (STEMI). In the study, drug-eluting stents outperformed bare-metal stents, and high-dose tirofiban, an anti-clotting medication, proved to be equally effective and have fewer side... (PR Newswire)

    Tailored Clopidogrel Dosing Improves PCI Outcomes  Mar 30, 2008
    Blood test monitors each patient's response to anti-clotting drug CHICAGO, March 29 /PRNewswire/ -- Using a simple blood test to individualize the loading dose of a medication that prevents blood clotting significantly reduces the risk of major cardiovascular complications after percutaneous coronary interventions (PCI), according to a multicenter study reported today in a Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2)... (PR Newswire)

    Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery  Mar 30, 2008
    Quality of PCI program is critical CHICAGO, March 29 /PRNewswire/ -- Percutaneous coronary intervention (PCI) can be performed safely and successfully in medical centers without on-site cardiac surgical back-up, provided programs are well-organized, highly skilled and committed to quality. These are the findings of the largest clinical study ever to compare PCI programs that have on-site cardiac surgery to PCI programs that transfer patients to a surgical hospital in case of emergency. (PR Newswire)

    ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI  Mar 30, 2008
    CHICAGO, March 29 /PRNewswire/ -- A large randomized trial will shed light on the ideal combination of medications for preventing unwanted blood clotting during and shortly after percutaneous coronary intervention (PCI). Specifically, study investigators expect to determine whether bivalirudin, a direct inhibitor of the clotting protein thrombin, is better than unfractionated heparin, an indirect thrombin inhibitor, in patients who have also been treated with high-dose clopidogrel. (PR Newswire)

    Largest Ever Analysis Of DES Data Demonstrates Safety, Efficacy In On-and-off-label Use  Mar 30, 2008
    2, 2007) The use of slow-release drugs in stents (drug-eluting stents) has dramatically reduced restenosis rates after percutaneous coronary intervention. However, these permanent metal devices may impair. (Science Daily)

    New Drug Shows Promise in Use With Coronary Stents  Mar 29, 2008
    "These data highlight the importance of aggressive antiplatelet therapy to reduce ischemic events in patients with acute coronary syndromes undergoing percutaneous coronary intervention," the study authors concluded. "When balancing risks and benefits of strategies to prevent ischemic events, consideration should be given to patient characteristics, including risk of bleeding and ischemic events as well as stent and procedural characteristics.". (Health-Finder)

    Research To Lead To Brain Tumor Therapies  Mar 25, 2008
    (May 1, 2006) Percutaneous cryoablation, a relatively non-invasive technique that destroys tumors by freezing them, is a safe method for treating kidney tumors in selected patients who are not considered. (May 22, 2005) The use of expandable electrodes with multiple tips in the treatment of liver tumors by radiofrequency ablation (RFA) is safe and effective, making it a useful alternative to surgery in selected. (Science Daily)

    Drug Therapy Boosting Heart-Attack Survival Rates  Mar 25, 2008
    "We know that PCI [percutaneous coronary intervention, or angioplasty] improves survival in the acute phase of a heart attack," Maron said. "The best short-term therapy is reperfusion, preferably with PCI. As a complement to that, there needs to be long-term therapy for atherosclerosis.". (Health-Finder)

    Treatment Gives Lung Cancer Patients With Inoperable Tumors Two Years Or More, Study Shows  Mar 23, 2008
    The study Long-term Follow-up After Percutaneous Pulmonary Radiofrequency Ablation was presented at the Society of Interventional Radiology s 33rd Annual Scientific Meeting on March 17, 2008. Adapted from materials provided by. (Science Daily)

    Cardium Reports on Recent Highlights and Financial Results  Mar 15, 2008
    Corgentin is a DNA therapeutic based on the localized and sustained cardiac production of insulin-like growth factor-1 (IGF-1) following a single intracoronary administration in an acute care setting immediately after percutaneous coronary intervention in heart attack patients. Financial Report For the year ended December 31, 2007, Cardium reported net operating losses totaling $25. (PR Newswire)

    Statins Exert Class Effect in Heart Failure  Mar 15, 2008
    The protection afforded by statin treatment persisted after Pilote and colleagues excluded patients with a prior heart attack, percutaneous coronary intervention, or coronary artery bypass graft surgery within the 3 years before or during they were hospitalized. "Our study demonstrates that statins exert a class effect in patients with CHF, at relatively low dose," the investigators conclude. (MEDLINEplus)

    New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)  Mar 5, 2008
    The new 300mg tablet will facilitate the use of the approved loading dose of Plavix(R) and the early initiation as recommended by national and international guidelines in appropriate patients with acute coronary syndrome (ACS), including those with unstable angina / non-ST segment elevation myocardial infarction (managed with percutaneous intervention (PCI) with or without stent or medically managed) and ST segment elevation myocardial infarction patients. The 300mg tablet is bioequivalent to... (PR Newswire)

    Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call  Mar 1, 2008
    Surgical products and accessories for the company's minimally invasive Percutaneous Myocardial Channeling (PMC) procedure are currently being marketed in Europe and other international markets. For more information on the company and its products, please visit the Cardiogenesis company website at or the direct to patient website at. (PR Newswire)

    Polk EMS honored for fast transport times  Feb 29, 2008
    This technique, percutaneous coronary intervention (PCI), is credited for reducing fatalities from cardiac arrest. This procedure involves inserting a balloon catheter, with which a physician is able to remove a blood clot and install. (Cedartown Standard, GA)

    Oldest Patients Fare Well After Heart Valve Surgery  Feb 27, 2008
    Surgeons are investigating a less invasive version of the surgery known as percutaneous valve replacement, which remains in the experimental stages, the researcher noted. Some have argued for testing the procedure in older people, he added, based on the assumption that these patients don't have long to live so it won't matter as much if the repair doesn't last. (MEDLINEplus)

    UK heart doctor, journal bound for St. Joseph's  Feb 26, 2008
    In particular, a procedure that allows replacement of heart valves without surgery -- known as percutaneous valve replacement -- likely will be a popular subject for the journal. "That is one reason why I accepted the position; the journal is a perfect place to share knowledge on the subject with the community," he said. (Twin Cities Business Journal, MN)

    The importance of left ventricular function in long-termprognosis after primary percutaneous coronary intervention  Feb 24, 2008
    The importance of left ventricular function in long-term prognosis after primary percutaneous coronary intervention ... In the present study we sought to determine the long-term prognostic value of left ventricular ejection fraction (LVEF), assessed by planar radionuclide ventriculography (PRV), after ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PPCI). (BioMed Central)

    Dramatic Improvement In Aortic Valve Surgery Using Least Invasive Valve Replacement Procedure, Study Shows  Feb 14, 2008
    Lead author Eugene Grossi, M.D., Professor of Cardiothoracic Surgery and Director of Cardiac Surgical Research at NYU Medical Center, stated percutaneous aortic valve replacement (PAVR) trials are ongoing in patients with elevated EuroSCOREs ... Clinical trials for using Percutaneous Valve Procedures for high risk aortic valve replacement must include randomized surgical controls and have long-term endpoints ... 23, 2007) Three new studies evaluate a rapidly advancing field within interventional... (Science Daily)

    Patients At Increased Risk Of Heart Attack Within 3 Months After Stopping Clopidogrel Therapy, Study Shows  Feb 11, 2008
    Randomized trials have established the effectiveness of clopidogrel therapy following hospitalization for acute coronary syndrome (ACS) for patients treated either medically or with percutaneous coronary intervention (PCI - procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) ... (May 14, 2007) Pretreatment with double-dose anticlotting medication just before percutaneous coronary intervention cuts the combined risk of heart attack and cardiac death... (Science Daily)

    Novel Compound May Lessen Heart Attack Damage, Initial Tests Show  Feb 9, 2008
    The drug, known as KAI-9803, blocks the activity of an enzyme called delta protein kinase C that triggers cell and tissue death in the aftermath of percutaneous coronary intervention, or PCI. PCI is a set of procedures including balloon angioplasty and stent placement that clear and prop open clogged coronary blood vessels that lead to a heart attack -- a process known as reperfusion. Although the trial (known as DELTA-MI) was not designed to demonstrate the efficacy of KAI-9803, researchers say... (Science Daily)

    Increased Risk of Death When Plavix Stopped  Feb 7, 2008
    Study groups included those treated medically and those who underwent percutaneous interventions. Both groups showed dramatic increase in incidence of myocardial infarction and death in the first 90 days following cessation of clopidogrel therapy, as compared to the period after the first three months. (MedHeadlines)

    Common Drug-releasing Coronary Stents Appear To Have Similar Clinical Outcomes  Feb 4, 2008
    Drug-releasing (eluting) stents are used for percutaneous coronary interventions (PCI) to help reduce the rate of re-narrowing of a coronary artery, according to background information in the article. Approval of drug-eluting coronary stents was based on results of relatively small trials of selected patients; however, in routine practice, stents are used in a broader spectrum of patients. (Science Daily)

    Biopure Announces 2007 Fourth Quarter and Year-End Financial Results  Jan 29, 2008
    Our first pilot ischemia trial was designed to assess the product's safety in patients with single-vessel coronary artery disease who were undergoing angioplasty and stenting procedures, or percutaneous coronary intervention (PCI). This Phase 2 trial, completed in 2005, enrolled a total of 45 evaluable patients at five hospitals in Germany, Belgium and The Netherlands. (PR Newswire)

    Citywide Program for Primary Angioplasty  Jan 17, 2008
    Background If primary percutaneous coronary intervention (PCI) is performed promptly, the procedure is superior to fibrinolysis in restoring flow to the infarct-related artery in patients with ST-segment elevation myocardial infarction. The benchmark for a timely PCI intervention has become a door-to-balloon time of less than 90 minutes. (New England Journal of Medicine)

    How Less Can Be More When Treating Some Kidney Cancers  Jan 11, 2008
    (May 1, 2006) Percutaneous cryoablation, a relatively non-invasive technique that destroys tumors by freezing them, is a safe method for treating kidney tumors in selected patients who are not considered. (Nov. (Science Daily)

    OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial  Jan 10, 2008
    "Genous is a viable alternative to drug-eluting stents, which have raised many safety concerns among the interventional cardiology community. Unlike TAXUS and CYPHER that elute cytotoxic agents to inhibit neointimal proliferation, Genous attracts circulating endothelial progenitor cells to rapidly build a layer of healthy tissue and promote long-term natural healing." The study involved 195 consecutive high-risk patients who underwent percutaneous coronary intervention (PCI) with either GRS or... (PR Newswire)

    Similar Outcomes For Patients With ACS Treated With Different Anticoagulant Regimens  Jan 3, 2008
    "Early angiography followed by interventional or surgical revascularization when appropriate has been shown to result in reduced rates of death, myocardial infarction (MI), refractory ischemia, and rehospitalization in patients with acute coronary syndromes (ACS; unstable angina or non--ST-segment elevation MI [a certain pattern on an electrocardiogram following a heart attack]). Because both MI and hemorrhagic complications have been associated with early and late mortality in patients with ACS... (Science Daily)

    'False-positive' Activation Of Cardiac Catheterization May Occur In Some With Suspected Heart Attack  Dec 22, 2007
    The patients were part of a registry from a regional system that included transfer of patients with STEMI from 30 community and rural hospitals with pre-transfer catheterization laboratory activation for percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) at a tertiary cardiovascular center in Minnesota. Of the 1,335 patients with suspected STEMI who underwent angiography, 187 (14 percent) did not have a... (Science Daily)

    Top10 research advances include studies on genetics and stem cell research, stents  Dec 21, 2007
    This study compared the initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) vs. optimal medical therapy alone in reducing the risk of cardiovascular events. The authors concluded that, as an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction or other major cardiovascular events when added to optimal... (EurekAlert!)

    Exercise Testing May Help Predict Seriousness Of Mitral Regurgitation  Dec 18, 2007
    23, 2007) Three new studies evaluate a rapidly advancing field within interventional cardiology: percutaneous procedures to repair and replace defective heart valves. Percutaneous valve procedures, which are. (Science Daily)

    Subclavian Catheterization  Dec 13, 2007
    Fortune JB, Feustel P. Effect of patient position on size and location of the subclavian vein for percutaneous puncture. Arch Surg 2003;138:996-1000. (New England Journal of Medicine)

    Archives: PNL Nephrolithotripsy

    Back to Health News

[ Terms Of Use | Privacy | About ]
©1998-2008 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2008